Streptococcus pyogenes, or group A beta-hemolytic streptococcus (GABHS), is responsible for both localized infections such as sore throats and mild skin infections, as well as severe...

In 2005, the rate of macrolide resistance among GAS was estimated in France to be between 16% and 31%; however, no ad hoc epidemiological study had previously attempted to refine this...

Streptococcus pyogenes, or group A streptococcus (GAS), is a rare cause of nosocomial infection. In France in 2002, it was isolated in 0.3% of nosocomial bacteremias. The case fatality...

Key Points In 2023, the annual incidence of pediatric HUS was lower than in 2022 (a year marked by a particularly high incidence linked to the occurrence of several outbreaks). It was...

The full questionnaire for the 2023 Santé publique France Public Health Barometer is presented in this document. Administered by telephone, it includes the instructions displayed on the...

Following the detection of poliovirus type PVDV 3, derived from the Sabin vaccine strain, in wastewater in French Guiana, Santé publique France is reiterating the importance of...

As they do every year, starting Friday, November 1, 2024, Santé publique France and the Ministry of Health and Access to Healthcare, in collaboration with the National Health Insurance,...

Key points Bronchiolitis Activity at SOS Médecins clinics related to bronchiolitis is within the usual range for this time of year. Emergency department activity is low and slightly...

Key Points Dengue Dengue circulation remains at a sub-epidemic level in weeks 41–42. The level of circulation is low and decreasing compared to the previous two weeks (weeks...

Key points Martinique Flu: indicators generally stable, with a decrease in the number of outpatient visits Bronchiolitis: has reached epidemic levels, with most indicators on the...